These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8865851)

  • 1. Losses at 3p common deletion sites in subtypes of kidney tumours: histopathological correlations.
    Hadaczek P; Podolski J; Toloczko A; Kurzawski G; Sikorski A; Rabbitts P; Huebner K; Lubinski J
    Virchows Arch; 1996 Sep; 429(1):37-42. PubMed ID: 8865851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas.
    Lubinski J; Hadaczek P; Podolski J; Toloczko A; Sikorski A; McCue P; Druck T; Huebner K
    Cancer Res; 1994 Jul; 54(14):3710-3. PubMed ID: 8033088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of 3p allelic loss in papillary and nonpapillary renal cell carcinomas. Correlation with tumor karyotypes.
    Hughson MD; Meloni A; Dougherty S; Silva FG; Sandberg AA
    Cancer Genet Cytogenet; 1996 Apr; 87(2):133-9. PubMed ID: 8625259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clear-cell and papillary carcinoma of the kidney: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification, cytogenetics, and fluorescence in situ hybridization.
    Hughson MD; Dickman K; Bigler SA; Meloni AM; Sandberg AA
    Cancer Genet Cytogenet; 1998 Oct; 106(2):93-104. PubMed ID: 9797772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
    Velickovic M; Delahunt B; Störkel S; Grebem SK
    Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis.
    Martinez A; Fullwood P; Kondo K; Kishida T; Yao M; Maher ER; Latif F
    Mol Pathol; 2000 Jun; 53(3):137-44. PubMed ID: 10897333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
    el-Naggar AK; Batsakis JG; Wang G; Lee MS
    Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant papillary renal tumors with extensive clear cell change: a molecular analysis by microsatellite analysis and fluorescence in situ hybridization.
    Salama ME; Worsham MJ; DePeralta-Venturina M
    Arch Pathol Lab Med; 2003 Sep; 127(9):1176-81. PubMed ID: 12946227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed microsatellite analysis of chromosome 3p region in non-papillary renal cell carcinomas.
    Chudek J; Wilhelm M; Bugert P; Herbers J; Kovacs G
    Int J Cancer; 1997 Oct; 73(2):225-9. PubMed ID: 9335447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
    Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J
    Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristic loss of heterozygosity in chromosome 3P and low frequency of replication errors in sporadic renal cell carcinoma.
    Chino K; Esumi M; Ishida H; Okada K
    J Urol; 1999 Aug; 162(2):614-8. PubMed ID: 10411097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of multiple renal cell adenomas and carcinomas suggests allelic loss at 3p21 to be a prerequisite for malignant development.
    van den Berg A; Dijkhuizen T; Draaijers TG; Hulsbeek MM; Maher ER; van den Berg E; Störkel S; Buys CH
    Genes Chromosomes Cancer; 1997 Aug; 19(4):228-32. PubMed ID: 9258657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.
    Kardas I; Mrózek K; Babinska M; Krajka K; Hadaczek P; Lubinski J; Roszkiewicz A; Kuziemska E; Limon J
    Oncol Rep; 2005 May; 13(5):949-56. PubMed ID: 15809763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity at the familial RCC t(3;8) locus in most clear cell renal carcinomas.
    Druck T; Kastury K; Hadaczek P; Podolski J; Toloczko A; Sikorski A; Ohta M; LaForgia S; Lasota J; McCue P
    Cancer Res; 1995 Nov; 55(22):5348-53. PubMed ID: 7585599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.
    Ogawa O; Habuchi T; Kakehi Y; Koshiba M; Sugiyama T; Yoshida O
    Cancer Res; 1992 Apr; 52(7):1881-5. PubMed ID: 1348014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas.
    Herbers J; Schullerus D; Chudek J; Bugert P; Kanamaru H; Zeisler J; Ljungberg B; Akhtar M; Kovacs G
    J Pathol; 1998 Jan; 184(1):58-62. PubMed ID: 9582528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.